NRX Pharmaceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $972.00K, a 548.00% increase year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $451.00K, a 1118.92% increase year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $150.00K.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $37.00K.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2025 was $601.00K, a 1524.32% increase from fiscal 2024.
- NRX Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2024 was $37.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $972.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $601.00K 10-K · filed 2026-03-23 | |
| 2025-09-30 | $451.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $150.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $37.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $37.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |